Dendritic cells, the liver, and transplantation

Hepatology

Volumn 46, Issue 6, 2007, Pages 2021-2031

  Sumpter, Tina L ^a   Abe, Masanori ^c   Tokita, Daisuke ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CYTOKINE; ENDOTOXIN; FLT3 LIGAND; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ALCOHOLISM; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL STRUCTURE; CELLULAR IMMUNITY; CROSS TOLERANCE; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT RECIPIENT; HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER ISCHEMIA; LIVER REGENERATION; LIVER TRANSPLANTATION; LYMPHOID TISSUE; NATURAL KILLER T CELL; NONHUMAN; PATIENT MONITORING; PHENOTYPIC VARIATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; DENDRITIC CELLS; ENDOTOXINS; HUMANS; KILLER CELLS, NATURAL; LIVER; LIVER DISEASES; LIVER REGENERATION; LIVER TRANSPLANTATION; MICE; RATS; REPERFUSION INJURY; T-LYMPHOCYTES;

EID: 37749031215     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21974     Document Type: Review

References (112)

1. Calne R, Stells R, Pena J, Davis D, Millard P, Herbertson B, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-476.
2. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. HEPATOLOGY 1994;19:916-924.
3. Farges O, Morris P, Dallman M. Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response. Transplantation 1994; 57:171-177.
4. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995;59:919-921.
5. Kamada N, Davies H, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981;292:840-842.
6. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000;174:21-34.
7. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004;4:24-35.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
9. Steiniger B, Klempnauer J, Wonigeit K. Phenotype and histological distribution of interstitial dendritic cells in the rat pancreas, liver, heart, and kidney. Transplantation 1984;38:169-174.
10. Woo J, Lu L, Rao AS, Li Y, Subbotin V, Starzl TE, et al. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation 1994;58:484-491.
11. Steptoe RJ, Fu F, Li W, Drakes ML, Lu L, Demetris AJ, et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol 1997; 159:5483-5491.
12. Lu L, Woo J, Rao AS, Li Y, Watkins SC, Qian S, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994;179:1823-1834.
13. Morelli AE, O'Connell PJ, Khanna A, Logar A, Lu L, Thomson AW. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation 2000;69:2647-2657.
14. O'Connell PJ, Morelli AE, Logar AJ, Thomson AW. Phenotypic and functional characterization of mouse hepatic CD8{alpha}+ lymphoid-related dendritic cells. J Immunol 2000;165:795-803.
15. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004;172:1009-1017.
16. Brenan M, Puklavec M. The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J Exp Med 1992;175:1457-1465.
17. Morelli AE, Coates PT, Shufesky WJ, Barratt-Boyes SM, Fung JJ, Demetris AJ, et al. Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation 2007;83:656-662.
18. Bosma B, Metselaar H, Mancham S, Boor P, Kusters J, Kazemier G, et al. Characterization of human liver dendritic cells in liver grafts and perfusates. Liver Transpl 2006;12:384-393.
19. Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004;164:511-519.
20. Abe M, Zahorchak A, Colvin B, Thomson AW. Migratory responses of murine hepatic myeloid, lymphoid-related and plasmacytoid dendritic cells to CC chemokines. Transplantation 2004;78:762-765.
21. Yrlid U, Cerovic V, Milling S, Jenkins CD, Zhang J, Crocker PR, et al. Plasmacytoid dendritic cells do not migrate in intestinal or hepatic lymph. J Immunol 2006;177:6115-6121.
22. Tanis W, Mancham S, Binda R, Janssen HL, Bezemer G, IJzermans JN, et al. Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. Clin Immunol 2004;110:81-88.
23. Lai WK, Curbishley SM, Goddard S, Alabrabra E, Shaw J, Youster J, et al. Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J Hepatol 2007;47:338-347.
24. Xiang Z, Lv J, Jiang P, Chen C, Jiang B, Burnstock G. Expression of P2X receptors on immune cells in the rat liver during postnatal development. Histochem Cell Biol 2006;126:453-463.
25. Geyeregger R, Zeyda M, Bauer W, Kriehuber E, Saemann MD, Zlabinger GJ, et al. Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. Blood 2007;109:4288-4295.
26. Lian Z-X, Okada T, He X-S, Kita H, Liu Y-J, Ansari AA, et al. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol 2003;170:2323-2330.
27. Pillarisetty VG, Katz SC, Bleier JI, Shah AB, DeMatteo RP. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-{gamma} via autocrine IL-12. J Immunol 2005;174:2612-2618.
28. Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk M, et al. CD40L blockade prevents autoimmune diabetes by induction of biotypic NK/DC regulatory cells. Immunity 2002;16:403-415.
29. Roncarolo MG, Bigler M, Haanen JB, Yssel H, Bacchetta R, de Vries JE, et al. Natural killer cell clones can efficiently process and present protein antigens. J Immunol 1991;47:781-787.
30. Miggin S, O'Neill L. New insights into the regulation of TLR signaling. J Leukoc Biol 2006;80:220-226.
31. Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189.
32. Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Dendritic cells expand antigen-specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 2006;212:314-329.
33. Abe M, Tokita D, Raimondi G, Thomson AW. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol 2006;36:2483-2493.
34. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005;174:2037-2045.
35. Kingham T, Chaudhry U, Plitas G, Katz S, Raab J, DeMatteo R. Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion. HEPATOLOGY 2007;45:445-454.
36. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995;60:1366-1370.
37. Abe M, Akbar S, Horiike N, Onji M. Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 2001;34:61-67.
38. Lu L, Woo J, Rao AS, Li Y, Watkins SC, Qian S, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994;179:1823-1834.
39. Khanna A, Morelli AE, Zhong C, Takayama T, Lu L, Thomson AW. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000;164:1346-1354.
40. Lu L, Bonham CA, Liang X, Chen Z, Li W, Wang L, et al. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol 2001;166:7042-7052.
41. Bevan MJ. Cross-priming. Nat Immunol 2006;7:363-365.
42. Dolan BP, Gibbs KD Jr, Ostrand-Rosenberg S. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J Immunol 2006;177:6018-6024.
43. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J Immunol 2003;170:2302-2309.
44. Herrera OB, Golshayan D, Tibbott R, Ochoa FS, James MJ, Marelli-Berg FM, et al. A novel pathway of alloantigen presentation by dendritic cells. J Immunol 2004;173:4828-4837.
45. Smyth L, Herrera O, Golshayan D, Lombardi G, Lechler R. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation 2006;82(1 Suppl):S15-S18.
46. Klein I, Crispe IN. Complete differentiation of CD8+ T cells activated locally within the transplanted liver. J Exp Med 2006;203:437-447.
47. Cabillic F, Rougier N, Basset C, Lecouillard I, Quelvennec E, Toujas L, et al. Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response. J Hepatol 2006;44:552-559.
48. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004;173:4433-4442.
49. Ito T, Yang M, Wang YH, Lande R, Gregorio J, Perng OA, et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 2007;204:105-115.
50. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006;7:652-662.
51. Jiang X, Morita M, Sugioka A, Harada M, Kojo S, Wakao H, et al. The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance. Liver Transpl 2006;12:1112-1118.
52. Steger U, Kingsley C, Karim M, Bushell A, Wood K. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation 2006;82:1202-1209.
53. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000;174:5-20.
54. Eberl G, MacDonald H. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000;30:985-992.
55. Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Sakamori R, Ohkawa K, et at. Intrahepatic delivery of a-galactosylceramide-pulsed dendritic cells suppresses liver tumor. HEPATOLOGY 2007;45:22-30.
56. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006;203:1851-1858.
57. Jinushi M, Takehara T, Tatsumi T, Yamaguchi S, Sakamori R, Hiramatsu N, et al. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology 2007;120:73-82.
58. Steininger R, Roth E, Fugger R, Winkler S, Langle F, Grunberger T, et al. Transhepatic metabolism of TNF-alpha, IL-6, and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation 1994;58:179-183.
59. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003;111:1571-1578.
60. McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006;36:1994-2002.
61. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006;440:808-812.
62. Khan S, Bijker MS, Weterings JJ, Tanke HJ, Adema GJ, van Hall T, et al. Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells. J Biol Chem 2007;282:21145-21159.
63. Weck MM, Grunebach F, Werth D, Sinzger C, Bringmann A, Brossart P. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 2007;109:3890-3894.
64. Drakes ML, Lu L, Subbotin VM, Thomson AW. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J Immunol 1997;159:4268-4278.
65. Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, et al. IL-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol 2001;166:5619-5628.
66. Wysocka M, Montaner LJ, Karp CL. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis. J Immunol 2005;174:7398-7402.
67. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med 2000;193:35-50.
68. Matsuno K, Nomiyama H, Yoneyama H, Uwatoku R. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev Immunol 2002;9:143-149.
69. Uwatoku R, Suematsu M, Ezaki T, Saiki T, Tsuiji M, Irimura T, et al. Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of N-acetylgalactosamine-specific sugar receptors. Gastroenterology 2001;121:1460-1472.
70. Matsuno K, Ezaki T, Kudo S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: Their terminal division, active phagocytosis and translocation from the liver to the draining lymph. J Exp Med 1996;183:1865-1878.
71. Sato T, Yamamoto H, Sasaki C, Wake K. Maturation of rat dendritic cells during intrahepatic translocation evaluated using monoclonal antibodies and electron microscopy. Cell Tissue Res 1998;294:503-514.
72. van den Oord JJ, De Vos R, Facchetti F, Delabie J, De Wolf-Peeters C, Desmet VJ. Distribution of non-lymphoid, inflammatory cells in chronic HBV infection. J Pathol 1990;160:223-230.
73. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med 2001;193:35-49.
74. Kudo S, Matsuno K, Ezaki T, Ogawa M. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation. J Exp Med 1997;185:777-784.
75. Bishop GA, Sun J, DeCruz DJ, Rokahr KL, Sedgwick JD, Sheil AG, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996;156:4925-4931.
76. Okuda T, Ishikawa T, Azhipa O, Ichikawa N, Demetris A, Starzl T, et al. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation 2002;74:103-111.
77. low allograft dendritic cells migrate to the splenic red pulp in immunologically unresponsive rats. J Surg Res 2005;124:29-37.
78. Lu L, Rudert WA, Qian S, McCaslin D, Fu F, Rao AS, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995;182:379-387.
79. Rokahr K, Sharland A, Sun J, Wang C, Sheil A, Yan Y, et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998;95:257-263.
80. Sharland A, Yan Y, Wang C, Bowen DG, Sun J, Sheil AG, et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 1999;68:1736-1745.
81. Ninomiya T, Akbar S, Masumoto T, Horiike N, Onji M. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 1999;31:323-331.
82. Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, et al. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 2004;10:7260-7269.
83. Chen S, Akbar S, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K, et al. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 2000;148:49-57.
84. Lau AH, Abe M, Thomson AW. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2006;79:941-953.
85. Lau AH, Thomson AW, Colvin BL. Chronic ethanol exposure affects in vivo migration of hepatic dendritic cells to secondary lymphoid tissue. Hum Immunol 2007;68:577-585.
86. Wertheimer A, Bakke A, Rosen H. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. HEPATOLOGY 2004;40:335-345.
87. Nattermann J, Zimmermann H, Iwan A, von Lilienfeld-Toal M, Leifeld L, Nischalke H, et al. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. HEPATOLOGY 2006;44:945-954.
88. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004;190:1919-1926.
89. Bain C, Fatmi A, Zoulim F, Zarski J, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001;120:512-524.
90. Tsubouchi E, Akbar S, Murakami H, Horiike N, Onji M. Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol 2004;137:417-423.
91. Ulsenheimer A, Tilman Gerlach J, Jung M-C, Gruener N, Wächtler M, Backmund M, et al. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. HEPATOLOGY 2005;41:643-651.
92. van der Molen R, Sprengers D, Binda R, de Jong E, Niesters H, Kusters J, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. HEPATOLOGY 2004;40:738-746.
93. Zhang Z, Chen D, Yao J, Zhang H, Jin L, Shi M, et al. Increased infiltration of intrahepatic DC subsets closely correlate with vital control and liver injury in immune active pediatric patients with chronic hepatitis B. Clin Immunol 2007;122:173-180.
94. Schvoerer E, Thumann C, Shoprer S, Soulier E, Royer C, Brignon N. Doridot S, et al. Eary decrease in circulating dendritic cells number after liver transplantion could favor hepatitis C virus recurrence. J Med Virol 2006;78:1070-1075.
95. Burton JR Jr, Rosen H. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl 2006;11(Suppl 2):S38-S47.
96. Kwekkeboom J, Tha-In T, Tra W, Hop W, Boor P, Mancham S, et al. Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation. Am J Transplant 2005;5:2393-2402.
97. Loi P, Paulart F, Pajak B, Nagy N, Salmon I, Moser M, et al. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant Proc 2004;36:1275-1279.
98. Tsung A, Zheng N, Jeyabalan G, Izuishi K, Klune J, Geller D, et al. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 2007;81:1-10.
99. Tsoulfas G, Takahashi Y, Ganster R, Yagnik G, Guo Z, Fung J, et al. Activation of the lipopolysaccharide signaling pathway in hepatic transplantion preservation injury. Transplantation 2002;74:7-13.
100. Zhai Y, Shen XD, O'Connell R, Gao F, Lassman C, Busuttil RW, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004;173:7115-7119.
101. Tsung A, Hoffman R, Izuishi K, Critchlow N, Nakao A, Chan M, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005;175:7661-7668.
102. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201:1135-1143.
103. Tian J, Avalos A, Mao S, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007;8:487-496.
104. Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. HEPATOLOGY 2004;39:422-432.
105. Castellaneta A, Di Leo A, Francavilla R, Margiotta M, Barone M, Amoruso A, et al. Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice. HEPATOLOGY 2006;43:807-816.
106. Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-{alpha} and NF-{kappa}B. J. Exp. Med. 2005;201:473-484.
107. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. HEPATOLOGY 2005;41:443-450.
108. Campbell JS, Riehle KJ, Brooling JT, Bauer RL, Mitchell C, Fausto N. Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4. J Immunol 2006;176:2522-2528.
109. Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 2003;3:689-696.
110. Schvoerer E, Thumann C, Spohrer S, Soulier E, Royer C, Brignon N, et al. Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence. J Med Virol 2006;78:1070-1075.
111. Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 2005;5:314-322.
112. Gras J, Wieërs G, Vaerman J-L, Truong DQ, Sokal E, Otte J-B, et al. Early immunological monitoring after pediatric liver transplantation: Cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 2007;13:426-433.